SeaStar Medical
ICU | NASDAQ
$3.58
+$0.04 (+1.13%)
At close: Sep 21, 2026, 4:00 PM ET
$3.56
-$0.02 (-0.45%)
Pre-market:
Sep 22, 2026, 7:28 AM ET
+1.13%
(1D)Rating
Updated: Sep 9, 2026Key Statistics
Market Data
Market Cap $10.16M
1D Range
3.33 3.58
52W Range
2.07 12.50
Valuation (TTM)
PE -0.92
PB 2.36
EV/EBITDA -0.23
Valuation (NTM)
Forward PE N/A
Forward PEG 0.02
Price Target $8
Cash Flow
FCF Yield -134.8%
SBC Adj. FCF Yield -138.2%
SBC Impact -2.6%
Margins
Gross Margin 92.6%
Operating Margin -816.6%
FCF Margin -799.4%
Growth (CAGR)
Revenue 3Y | 5Y 103.7% |
84.5%
Dil EPS 3Y | 5Y 128.2% |
40.6%
FCF 3Y | 5Y -5.7% |
-16.6%
Returns
ROA -157.6%
ROE -162.8%
ROIC -325.6%
Financial Health
Net Cash
$6.96M
Current Ratio 1.89
Interest Coverage -518.11
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill indiv...
Sector Healthcare
Industry Biotechnology
Employees 18
IPO Date Mar 17, 2021
Website www.seastarmedical.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$8
Upside
+123.46%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ICU